KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Enterprise Value (2017 - 2025)

Historic Enterprise Value for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$580.0 million.

  • Guardant Health's Enterprise Value rose 3524.64% to -$580.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$580.0 million, marking a year-over-year increase of 3524.64%. This contributed to the annual value of -$840.0 million for FY2024, which is 2812.31% up from last year.
  • Guardant Health's Enterprise Value amounted to -$580.0 million in Q3 2025, which was up 3524.64% from -$629.1 million recorded in Q2 2025.
  • Guardant Health's Enterprise Value's 5-year high stood at -$580.0 million during Q3 2025, with a 5-year trough of -$1.9 billion in Q1 2021.
  • For the 5-year period, Guardant Health's Enterprise Value averaged around -$1.0 billion, with its median value being -$958.0 million (2022).
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 29635.1% in 2021, then soared by 5071.82% in 2022.
  • Over the past 5 years, Guardant Health's Enterprise Value (Quarter) stood at -$932.7 million in 2021, then decreased by 8.41% to -$1.0 billion in 2022, then fell by 15.57% to -$1.2 billion in 2023, then grew by 28.12% to -$840.0 million in 2024, then surged by 30.95% to -$580.0 million in 2025.
  • Its Enterprise Value stands at -$580.0 million for Q3 2025, versus -$629.1 million for Q2 2025 and -$698.6 million for Q1 2025.